Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
escitalopram + LABCAT TCJUSS
- Development stage
- Discontinued
- Lead developer
- Laboratório Catarinense
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
A combination product of **escitalopram**, a selective serotonin reuptake inhibitor (SSRI) antidepressant, and **LABCAT TCJUSS**, a proprietary or investigational compound developed by Laboratório Catarinense. It has been studied as adjunctive therapy for depressive episodes, aiming to improve core symptoms including anhedonia and global clinical impression versus escitalopram alone. Escitalopram acts by increasing serotonin levels in the synaptic cleft via inhibition of the serotonin transporter, while the mechanism and active ingredients of LABCAT TCJUSS are not described in current literature. Used orally for the treatment of depression, especially major depressive disorder.
- Other names
- escitalopram + LABCAT TCJUSS
02
Targets
SERT (Sodium-dependent serotonin transporter)
Beyond the preview
Go deeper on escitalopram + LABCAT TCJUSS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on escitalopram + LABCAT TCJUSS.